TLRY: Tilray Brands, Inc. Stock

by  •  • Comments Off on TLRY: Tilray Brands, Inc. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 813.60
Enterprise Value ($M) 909.78
Book Value ($M) 3,453.61
Book Value / Share 3.68
Price / Book 0.24
NCAV ($M) -30.81
NCAV / Share -0.03
Price / NCAV -26.41

Profitability (mra)
Return on Invested Capital (ROIC) -0.07
Return on Assets (ROA) -0.06
Return on Equity (ROE) -0.08

Liquidity (mrq)
Quick Ratio 1.58
Current Ratio 2.54

Balance Sheet (mrq) ($M)
Current Assets 707.34
Assets 4,191.75
Liabilities 738.15
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 788.94
Operating Income -96.33
Net Income -222.40
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -30.91
Cash from Investing 128.35
Cash from Financing -75.19

(click for more detail)
Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-01-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-10-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-10-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-04-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 26,882,554 62,785,395 42.82
2025-02-20 18,625,873 32,645,118 57.06
2025-02-19 26,903,849 55,745,900 48.26
2025-02-18 27,672,609 54,201,981 51.05

(click for more detail)

Similar Companies
TARS – Tarsus Pharmaceuticals, Inc. TECH – Bio-Techne Corporation
TERN – Terns Pharmaceuticals, Inc. TNYA – Tenaya Therapeutics, Inc.
TRML – Tourmaline Bio, Inc.


Financial data and stock pages provided by
Fintel.io